RENAL DENERVATION DEVICES MARKET ANALYSIS

Market Challenges And Opportunities

Renal Denervation Devices Market Restraints

• The high procedural costs associated with renal denervation devices and the procedure is a major factor restraining the growth of the global renal denervation devices market. Renal denervation is a minimally invasive procedure that uses a catheter-based ablation technique to deactivate the renal nerves and lower blood pressure in patients with uncontrolled high blood pressure. However, the entire cost of the renal denervation procedure is placed on the patient unlike pharmaceutical therapy where some costs may be covered by insurance.

Renal Denervation Devices Market Drivers

• The rising prevalence of hypertension globally is expected to drive the market growth over the forecast period. For instance, according to the data published by the Center for Disease Control and Prevention (CDC) on July 6, 2023, globally nearly half of adults have hypertension (48.1%, 119.9 million), defined as a systolic blood pressure greater than 130 mmHg or a diastolic blood pressure greater than 80 mmHg or are taking medication for hypertension.
• Increasing obese population globally will aid in the market growth over the forecast period. For instance, according to the data published by the World Health Organization (WHO) on June 9, 2021, more than 1.9 billion adults, and 18 years and older, were overweight.

Renal Denervation Devices Market Opportunities

• The emerging markets in Asia Pacific and Latin America regions present a great opportunity for growth in the global renal denervation devices market over the coming years. These regions are experiencing rapid economic development and growth in incomes. Along with growth, countries are witnessing significant changes in lifestyles and diets which is leading to rise in non-communicable diseases like hypertension.